| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |